A Geographically Weighted Cost-effectiveness Analysis of Newborn Cytomegalovirus Screening.

ABSTRACT:

Background

Early identification of newborns with congenital cytomegalovirus (CMV) is necessary to provide antiviral therapy and other interventions that can improve outcomes. Prior research demonstrates that universal newborn CMV screening would be the most cost-effective approach to identifying newborns who are infected. CMV is not uniformly prevalent, and it is uncertain whether universal screening would remain cost-effective in lower-prevalence neighborhoods. Our aim was to identify geographic heterogeneity in the cost-effectiveness of universal newborn CMV screening by combining a geospatial analysis with a preexisting cost-effectiveness analysis.

Methods

This study used the CMV testing results and zip code location data of 96 785 newborns in 7 metropolitan areas who had

SUBMITTER: Lantos PM 

PROVIDER: S-EPMC11200186 | biostudies-literature | 2024 Jun

REPOSITORIES: biostudies-literature